Journal of the Formosan Medical Association
Volume 109, Issue 2 , Pages 148-155, February 2010

Clinical Characteristics of Taiwanese Children With Congenital Adrenal Hyperplasia Caused by 21-Hydroxylase Deficiency in the Pre-screening Era

Department of Pediatrics, National Taiwan University Hospital and College of Medicine, National Taiwan University, Taipei, Taiwan

Received 11 February 2009; received in revised form 25 May 2009; accepted 25 June 2009.

Article Outline

Background/Purpose

Data about the clinical manifestations of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency (21-OHD) are lacking in Taiwan. Therefore, this study analyzed the clinical features of 21-OHD in Taiwanese children to improve the diagnosis of this disorder, and to provide background information regarding the ongoing neonatal screening program for 21-OHD in Taiwan.

Methods

Eighty children with 21-OHD, 39 with the salt-wasting (SW) type and 41 with the simple-virilizing (SV) type, were evaluated by a review of their medical records. Their clinical symptoms and signs, laboratory findings, and genetic mutations were analyzed.

Results

The most frequent features in 21-OHD patients were hyperpigmentation and signs of androgen excess. Clinical manifestations related to hyponatremia such as poor feeding, poor weight gain, and dehydration were noted most frequently in patients with SW-type 21-OHD. Five patients had low serum cortisol with elevated plasma adrenocorticotropic hormone levels, and 22 patients had elevated dehydroepiandros-terone sulfate levels. All had elevated blood levels of 17-hydroxyprogesterone, androstenedione and testosterone. Hyponatremia and hyperkalemia were detected in 29 patients with SW-type 21-OHD. In terms of molecular diagnosis, mutations at IVS2-12A/C → G and gene deletion were the most frequent mutations detected in SW-type 21-OHD, while I172N and mutation at IVS2-12A/C → G were most frequent in SV type.

Conclusion

Taiwanese children with 21-OHD have characteristic clinical findings such as hyperpigmentation, androgen excess, and failure to thrive. There is a good correlation between genotype and pheno-type. Laboratory tests, including serum 17-hydroxyprogesterone, androstenedione, and testosterone levels are more sensitive than serum cortisol or dehydroepiandrosterone sulfate levels for diagnosing 21-OHD in prepubertal children.

Key Words:  21-hydroxylase deficiency , congenital adrenal hyperplasia , CYP21A2

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Bongiovanni AM , Root AW . The adrenogenital syndrome . N Engl J Med . 1963;268:1283–1289
  2. White PC , New MI , Dupont B . Congenital adrenal hyper-plasia . N Engl J Med . 1987;316:1519–1524 1580-6.
  3. Dupont B , Oberfield SE , Smithwick EM , et al.   Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency) . Lancet . 1977;2:1309–1312
  4. White PC , New MI , Dupont B . HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation . Proc Natl Acad Sci USA . 1984;81:7505–7509
  5. White PC , Vitek A , Dupont B , et al.   Characterization of frequent deletions causing steroid 21-hydroxylase deficiency . Proc Natl Acad Sci USA . 1988;85:4436–4440
  6. Higashi Y , Tanae A , Inoue H , et al.   Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450(C21)] deficiency in humans: possible gene conversion products . Proc Natl Acad Sci USA . 1988;85:7486–7490
  7. Amor M , Parker KL , Globerman H , et al.   Mutation in the CYP21B gene (Ile-172-Asn) causes steroid 21-hydroxylase deficiency . Proc Natl Acad Sci USA . 1988;85:1600–1604
  8. Globerman H , Amor M , Parker KL , et al.   Nonsense mutation causing steroid 21-hydroxylase deficiency . J Clin Invest . 1988;82:139–144
  9. Urabe K , Kimura A , Harada F , et al.   Gene conversion in steroid 21-hydroxylase genes . Am J Hum Genet . 1990;46:1178–1186
  10. New MI , Lorenzen F , Lerner AJ , et al.   Genotyping steroid 21-hydroxylase deficiency: hormonal reference data . J Clin Endocrinol Metab . 1983;57:320–326
  11. Tsai WY , Lee JS , Hsiao PH , et al.   Genotype of classic congenital adrenal hyperplasia and the 60-minute adrenocor-ticotropic hormone stimulation test . J Formos Med Assoc . 1995;94:10–13
  12. Pang S , Murphey W , Levine LS , et al.   A pilot newborn screening program for congenital adrenal hyperplasia in Alaska . J Clin Endocrinol Metab . 1982;55:413–420
  13. Chu SY , Tsai WY , Chen LH , et al.   Neonatal screening for congenital adrenal hyperplasia in Taiwan: a pilot study . J Formos Med Assoc . 2002;101:691–694
  14. Schreiner F , Brack C , Salzgeber K , et al.   False negative 17-hydroxyprogesterone screening in children with classical congenital adrenal hyperplasia . Eur J Pediatr . 2008;167:479–481
  15. Greulich WW , Pyle SI . Radiographic Atlas of Skeletal Development of the Hand and Wrist . 2nd ed. Stanford: Stanford University Press; 1959;
  16. Wilson RC , Wei JQ , Cheng KC , et al.   Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene . J Clin Endocrinol Metab . 1995;80:1635–1640
  17. Ko TM , Kao CH , Ho HN , et al.   Congenital adrenal hyper-plasia. Molecular characterization . J Reprod Med . 1998;43:379–386
  18. Tung YC , Lee JS , Tsai WY , et al.   Physiological changes of adrenal androgens in childhood . J Formos Med Assoc . 2004;103:921–924
  19. White PC , Speiser PW . Congenital adrenal hyperplasia due to 21-hydroxylase deficiency . Endocr Rev . 2000;21:245–291
  20. Speiser PW , White PC . Congenital adrenal hyperplasia . N Engl J Med . 2003;349:776–788
  21. Lebovitz RM , Pauli RM , Laxova R . Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening . Am J Dis Child . 1984;138:571–573
  22. Virdi NK , Rayner PH , Rudd BT , et al.   Should we screen for congenital adrenal hyperplasia? A review of 117 cases . Arch Dis Child . 1987;62:659–662
  23. Thilén A , Larsson A . Congenital adrenal hyperplasia in Sweden 1969-1986. Prevalence, symptoms and age at diagnosis . Acta Paediatr Scand . 1990;79:168–175
  24. Kovács J , Votava F , Heinze G , et al.   Lessons from 30 years of clinical diagnosis and treatment of congenital adrenal hyperplasia in five middle European countries . J Clin Endocrinol Metab . 2001;86:2958–2964
  25. Tsai WY , Hsiao PH , Lee JS . Serum dehydroepiandrosterone sulfate and androstenedione concentrations in children with adrenal disorders . J Formos Med Assoc . 1998;97:135–138
  26. Rösler A , Levine LS , Schneider B , et al.   The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia . J Clin Endocrinol Metab . 1977;45:500–512
  27. Joint LWPES/ESPE CAH Working Group  . Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology . J Clin Endocrinol Metab . 2002;87:4048–4053
  28. Lee HH , Chao HT , Lee YJ , et al.   Identification of four novel mutations in the CYP21 gene in congenital adrenal hyper-plasia in the Chinese . Hum Genet . 1998;103:304–310
  29. Higashi Y , Hiromasa T , Tanae A , et al.   Effects of individual mutations in the P-450 (C21) pseudogene on the P-450 (C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency . J Biochem . 1991;109:638–644
  30. Speiser PW , Dupont J , Zhu D , et al.   Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency . J Clin Invest . 1992;90:584–595
  31. Krone N , Braun A , Roscher AA , et al.   Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive geno-typing in 155 unrelated, well defined patients from southern Germany . J Clin Endocrinol Metab . 2000;85:1059–1065
  32. Dolžan V , Stopar-Obreza M , Žerjav-Tanšek M , et al.   Mutational spectrum of congenital adrenal hyperplasia in Slovenian patients: a novel Ala15Thr mutation and Pro30Leu within a larger gene conversion associated with a severe form of the disease . Eur J Endocrinol . 2003;149:137–144

PII: S0929-6646(10)60035-6

doi:10.1016/S0929-6646(10)60035-6

Journal of the Formosan Medical Association
Volume 109, Issue 2 , Pages 148-155, February 2010

Article Tools